Skip to main content

Table 1 Preoperative data of the included pregnant women

From: Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial

Variables

Control group

Esketamine group

P value

Number

122

124

 

Age (year), mean ± SD

27.7 ± 4.8

28 ± 3.1

0.56

Pre-pregnancy BMI (kg/m2), mean ± SD

24.1 ± 3.1

24.5 ± 4.7

0.43

Gestational weeks, n (%)

  

0.85

 Full term

 Preterm

 Post term

101 (82.77)

14 (11.48)

7 (5.74)

106 (85.48)

12 (9.67)

6 (4.84)

 

Pregnancy complications, n (%)

   

 Gestational diabetes

 Gestational hypertension

 Gestational Low thyroid

13 (10.66)

21 (17.21)

32 (26.23)

12 (9.68)

24 (19.35)

35 (28.23)

0.84

0.74

0.78

Gravidity, n (%)

  

0.80

 0

 ≥1

47 (38.52)

75 (61.48)

50 (40.32)

74 (59.68)

 

Parity, n (%)

  

0.80

 0

 ≥1

61 (50)

61 (50)

65 (52.42)

59 (47.58)

0.80

Marital status, n (%)

  

0.61

 Married

 Divorced

 Unmarried

121 (99.18)

0 (0)

1 (0.82)

122 (98.39)

1 (0.81)

1 (0.81)

 

Educational level, n (%)

  

0.43

 Master or above

 Bachelor or below

43 (35.25)

79 (64.75)

50 (40.32)

74 (59.68)

 

Stress hormone levels, mean ± SD

   

 Free cortisol (FC) (nmol/L)

261.51 ± 55.32

251.98 ± 62.23

0.21

 Atrial natriuretic peptide (ANP) (ng/mL)

0.54 ± 0.25

0.59 ± 0.19

0.08

 Epinephrine (E) (ng/L)

37.09 ± 4.32

35.92 ± 5.39

0.06

 Norepinephrine (NE) (ng/L)

159.82 ± 32.21

155.16 ± 43.13

0.34

Inflammation-inducing factors, mean ± SD

   

 C-reactive protein (CRP) (mg/dl)

0.32 ± 0.11

0.34 ± 0.09

0.12

 Interleukin-6 (IL-6) (pg/mL)

2.30 ± 0.7

2.11 ± 1.01

0.11

 Brain-derived neurotrophic factor (BDNF) (pg/mL)

1.31 ± 0.09

1.29 ± 0.12

0.14

Edinburgh Postpartum Depression Scale, mean ± SD

4.0 ± 2.1

3.6 ± 3.0

0.23

  1. SD, Standard Deviation